SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-20-056636
Filing Date
2020-12-10
Accepted
2020-12-10 07:19:05
Documents
14
Period of Report
2020-12-09
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K - 12-20 alks-8k_20201209.htm   iXBRL 8-K 60903
2 EX-10.1 alks-ex101_38.htm EX-10.1 153694
3 EX-99.1 alks-ex991_15.htm EX-99.1 50823
  Complete submission text file 0001564590-20-056636.txt   441903

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA alks-20201209.xsd EX-101.SCH 5776
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE alks-20201209_lab.xml EX-101.LAB 19413
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alks-20201209_pre.xml EX-101.PRE 11606
7 EXTRACTED XBRL INSTANCE DOCUMENT alks-8k_20201209_htm.xml XML 3531
Mailing Address CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN 4 L2 00000
Business Address CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN 4 L2 00000 00-353-1-772-8000
Alkermes plc. (Filer) CIK: 0001520262 (see all company filings)

IRS No.: 981007018 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35299 | Film No.: 201379419
SIC: 2834 Pharmaceutical Preparations